首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1448385

凝血分析仪的全球市场规模、份额和成长分析：按产品和最终用户 - 产业预测（2024-2031）

Global Coagulation Analyzer Market Size, Share, Growth Analysis, By Product(Standalone and Integrated systems), By End-user(Hospitals, Diagnostic centers) - Industry Forecast 2024-2031

出版日期: 2024年03月06日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球凝血分析仪市场规模将为44.3亿美元，预测期内（2024-2031年）复合年增长率为6.0%，从2023年的47亿美元增长到2031年的74亿美元。预计将增长到美国8000万美元。

心血管疾病和凝血障碍的盛行率不断上升，推动了全球凝血分析仪市场的显着成长。抗凝血治疗的监测和管理在很大程度上依赖这些分析设备。技术开拓可以实现更快、更准确的观察，再加上不断上涨的医疗成本，正在推动市场发展。易于使用的便携式设备越来越受欢迎。主要相关人员专注于改善患者治疗效果的创造性方法。

然而，严格的法规和定价要求带来了挑战。市场占有率主要由北美和欧洲占据，亚太地区显示出成长潜力。由于对有效凝血监测的需求不断增加，预计该市场将继续成长。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Roche Diagnostics-Switzerland
Siemens Healthineers-Germany
Abbott Laboratories-United States
Sysmex Corporation-Japan
Thermo Fisher Scientific-United States
Instrumentation Laboratory（IL）-United States
Helena Laboratories-United States
Nihon Kohden-Japan
Diagnostica Stago-France
Werfen-Spain
Grifols-Spain
International Technidyne Corporation（ITC）-United States
CoaguSense-United States
HemoSonics-United States
Helena Biosciences-United Kingdom
Randox Laboratories-United Kingdom
Helena Point of Care-United States
Medtronic-Ireland
EKF Diagnostics-United Kingdom
Hycor Biomedical-United States

简介目录

Product Code: SQMIG35A2462

Global Coagulation Analyzer Market size was valued at USD 4.43 billion in 2022 and is poised to grow from USD 4.70 billion in 2023 to USD 7.48 billion by 2031, at a CAGR of 6.0% during the forecast period (2024-2031).

The growing prevalence of cardiovascular illnesses and clotting disorders is driving substantial growth in the global market for coagulation analyzers. Anticoagulant therapy monitoring and management depend heavily on these analyzers. Technological developments that allow for quicker and more precise findings, combined with rising healthcare costs, are driving the market. Devices that are easy to use and portable are becoming more popular. Important actors are concentrating on creative ways to improve patient outcomes.

Strict rules and pricing demands, however, provide difficulties. The market share is dominated by North America and Europe, with Asia-Pacific showing potential for growth. All things considered, the market is expected to keep growing because of the increasing demand for effective coagulation monitoring.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Coagulation Analyzer Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Coagulation Analyzer Market Segmental Analysis

The product type, end-user, and geographic segments of the worldwide coagulation analyzer market may be distinguished. Integrated and stand-alone systems are among the product kinds. Research institutes, hospitals, and diagnostic centers are examples of end-users. North America, Europe, Asia-Pacific, and the rest of the globe make up the market's geographical boundaries.

Drivers of the Global Coagulation Analyzer Market

Aging populations around the world are linked to a higher risk of a number of illnesses, including coagulation disorders. The need for coagulation analyzers to diagnose and track clotting disorders including hemophilia and deep vein thrombosis (DVT) is expected to rise with the aging population.

Restraints in the Global Coagulation Analyzer Market

The cost of buying and maintaining coagulation analyzers can be high, particularly for smaller healthcare facilities and areas with limited resources. For healthcare providers, the initial expenditure, as well as expenses for reagents, maintenance, and routine calibration, can be very costly.

Market Trends of the Global Coagulation Analyzer Market

Automation and Technological improvements: The market for coagulation analyzers has been seeing a trend toward greater automation and technological improvements. The goal of manufacturers was to create analyzers with better efficiency, accuracy, and user interfaces. Automation elements that were becoming increasingly widespread included sample loading automation, barcode scanning, and interaction with laboratory information systems. These developments were made with the intention of improving overall laboratory productivity, streamlining testing procedures, and lowering human error.

Growing requirement for Point-of-Care Testing: The requirement for quick results and decentralized testing led to an increase in the demand for point-of-care coagulation testing. Healthcare professionals now have access to real-time information regarding a patient's coagulation status in a variety of clinical settings, including operating rooms, critical care units, and emergency departments, thanks to point-of-care coagulation analyzers. Patients on anticoagulant therapy or those with bleeding issues should pay special attention to this development.

Growing Emphasis on Patient-Centric Care and Personalized Medicine: The market for coagulation analyzers was being impacted by the shift in healthcare trends toward patient-centric care and personalized medicine. More emphasis was being placed by laboratories and healthcare practitioners on individualized treatment programs that took into account the unique characteristics of each patient, including coagulation profiles. To support these individualized treatment approaches, coagulation analyzers that could give precise and thorough data on a patient's coagulation status were in high demand.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Coagulation Analyzer Market by Product

Market Overview
Standalone and Integrated systems

Global Coagulation Analyzer Market by End-user

Market Overview
Hospitals
Diagnostic centers
and Research institutes

Global Coagulation Analyzer Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Roche Diagnostics - Switzerland
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Instrumentation Laboratory (IL) - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helena Laboratories - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diagnostica Stago - France
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Werfen - Spain
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols - Spain
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
International Technidyne Corporation (ITC) - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CoaguSense - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HemoSonics - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helena Biosciences - United Kingdom
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories - United Kingdom
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helena Point of Care - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic - Ireland
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EKF Diagnostics - United Kingdom
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hycor Biomedical - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments